US Stock MarketDetailed Quotes

ALGS Aligos Therapeutics

Watchlist
  • 9.550
  • -0.230-2.35%
Close Nov 1 16:00 ET
  • 9.600
  • +0.050+0.52%
Post 20:02 ET
30.52MMarket Cap-658P/E (TTM)

Aligos Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-43.16%-19.49M
-1.60%-22.75M
0.49%-79M
-35.01%-22.66M
-18.67%-20.34M
45.61%-13.62M
-9.56%-22.39M
31.36%-79.39M
55.22%-16.78M
32.45%-17.14M
Net income from continuing operations
126.93%5.06M
-51.88%-34.86M
8.71%-87.68M
-27.44%-27.89M
3.11%-18.04M
5.69%-18.79M
35.55%-22.96M
25.16%-96.05M
41.97%-21.89M
43.79%-18.62M
Operating gains losses
---30.48M
--14.37M
--2.19M
--2.17M
----
----
----
----
----
----
Depreciation and amortization
-20.68%610K
-20.14%674K
-16.49%3.07M
-13.60%775K
-24.83%681K
-13.50%769K
-14.14%844K
-2.73%3.68M
-11.45%897K
-6.31%906K
Change In working capital
539.35%4.11M
-49.58%-5.49M
-513.72%-9.53M
-133.87%-293K
-118.07%-6.2M
106.45%643K
-135.31%-3.67M
66.63%-1.55M
119.43%865K
-189.21%-2.84M
-Change in payables and accrued expense
572.70%4M
-56.91%-4.48M
82.46%-1.3M
-1.00%4.15M
-264.63%-1.76M
88.49%-846K
46.50%-2.85M
-178.67%-7.42M
-2.01%4.19M
-79.18%1.07M
-Change in other current assets
-93.63%138K
-90.22%204K
-56.79%2.3M
-105.06%-1.18M
-236.19%-779K
9.62%2.17M
-37.58%2.09M
165.86%5.32M
92.67%-573K
1,605.26%572K
-Change in other current liabilities
-5.17%-631K
-8.90%-636K
-22.23%-2.39M
-1.46%-627K
-52.52%-575K
34.14%-600K
-1,169.57%-584K
-18.37%-1.95M
-11.75%-618K
-5.31%-377K
-Change in other working capital
896.05%605K
74.73%-587K
-425.14%-8.14M
-23.62%-2.64M
24.65%-3.09M
97.94%-76K
-118.68%-2.32M
157.40%2.5M
-482.56%-2.14M
-167.08%-4.11M
Cash from discontinued investing activities
Operating cash flow
-43.16%-19.49M
-1.60%-22.75M
0.49%-79M
-35.01%-22.66M
-18.67%-20.34M
45.61%-13.62M
-9.56%-22.39M
31.36%-79.39M
55.22%-16.78M
32.45%-17.14M
Investing cash flow
Cash flow from continuing investing activities
59.95%39.99M
-543.37%-88.64M
271.08%44.98M
-100.06%-7K
-100.03%-9K
350.64%25M
133.10%19.99M
-970.05%-26.29M
170.42%11.6M
81,307.50%32.48M
Net PPE purchase and sale
-150.00%-7K
-885.71%-69K
97.99%-19K
92.31%-7K
-533.33%-19K
104.19%14K
98.64%-7K
-5.72%-943K
72.92%-91K
96.91%-3K
Net investment purchase and sale
60.06%40M
-542.87%-88.57M
277.51%45M
--0
-99.97%10K
359.18%24.99M
133.40%20M
-747.68%-25.35M
172.45%11.7M
56,892.98%32.49M
Cash from discontinued investing activities
Investing cash flow
59.95%39.99M
-543.37%-88.64M
271.08%44.98M
-100.06%-7K
-100.03%-9K
350.64%25M
133.10%19.99M
-970.05%-26.29M
170.42%11.6M
81,307.50%32.48M
Financing cash flow
Cash flow from continuing financing activities
-32.13%281K
-1,800.00%-19K
53,758.54%88.33M
72,574.38%87.94M
-10.53%-21K
398.80%414K
95.24%-1K
-99.79%164K
-78.08%121K
-100.02%-19K
Net issuance payments of debt
65.96%-16K
20.83%-19K
-57.38%-96K
-114.81%-4K
25.00%-21K
-62.07%-47K
22.58%-24K
22.78%-61K
235.00%27K
-27.27%-28K
Net common stock issuance
----
----
--17.44M
----
----
----
----
--0
----
----
Proceeds from stock option exercised by employees
-35.57%297K
--0
31,447.11%70.98M
74,896.81%70.5M
--0
311.61%461K
130.00%23K
-78.51%225K
-86.94%94K
-50.00%9K
Cash from discontinued financing activities
Financing cash flow
-32.13%281K
-1,800.00%-19K
53,758.54%88.33M
72,574.38%87.94M
-10.53%-21K
398.80%414K
95.24%-1K
-99.79%164K
-78.08%121K
-100.02%-19K
Net cash flow
Beginning cash position
-69.18%24.37M
66.67%135.77M
-56.43%81.46M
-18.51%70.5M
27.64%90.87M
-25.49%79.07M
-56.43%81.46M
-15.37%186.98M
-64.01%86.52M
-62.10%71.19M
Current changes in cash
76.08%20.78M
-4,551.65%-111.41M
151.47%54.31M
1,390.45%65.27M
-232.88%-20.37M
133.79%11.8M
97.04%-2.4M
-210.69%-105.52M
90.53%-5.06M
-70.83%15.33M
End cash Position
-50.32%45.15M
-69.18%24.37M
66.67%135.77M
66.67%135.77M
-18.51%70.5M
27.64%90.87M
-25.49%79.07M
-56.43%81.46M
-56.43%81.46M
-64.01%86.52M
Free cash flow
-43.29%-19.5M
-1.88%-22.82M
1.64%-79.02M
-34.32%-22.67M
-18.72%-20.35M
46.36%-13.61M
-6.90%-22.39M
31.08%-80.33M
55.38%-16.87M
32.69%-17.14M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -43.16%-19.49M-1.60%-22.75M0.49%-79M-35.01%-22.66M-18.67%-20.34M45.61%-13.62M-9.56%-22.39M31.36%-79.39M55.22%-16.78M32.45%-17.14M
Net income from continuing operations 126.93%5.06M-51.88%-34.86M8.71%-87.68M-27.44%-27.89M3.11%-18.04M5.69%-18.79M35.55%-22.96M25.16%-96.05M41.97%-21.89M43.79%-18.62M
Operating gains losses ---30.48M--14.37M--2.19M--2.17M------------------------
Depreciation and amortization -20.68%610K-20.14%674K-16.49%3.07M-13.60%775K-24.83%681K-13.50%769K-14.14%844K-2.73%3.68M-11.45%897K-6.31%906K
Change In working capital 539.35%4.11M-49.58%-5.49M-513.72%-9.53M-133.87%-293K-118.07%-6.2M106.45%643K-135.31%-3.67M66.63%-1.55M119.43%865K-189.21%-2.84M
-Change in payables and accrued expense 572.70%4M-56.91%-4.48M82.46%-1.3M-1.00%4.15M-264.63%-1.76M88.49%-846K46.50%-2.85M-178.67%-7.42M-2.01%4.19M-79.18%1.07M
-Change in other current assets -93.63%138K-90.22%204K-56.79%2.3M-105.06%-1.18M-236.19%-779K9.62%2.17M-37.58%2.09M165.86%5.32M92.67%-573K1,605.26%572K
-Change in other current liabilities -5.17%-631K-8.90%-636K-22.23%-2.39M-1.46%-627K-52.52%-575K34.14%-600K-1,169.57%-584K-18.37%-1.95M-11.75%-618K-5.31%-377K
-Change in other working capital 896.05%605K74.73%-587K-425.14%-8.14M-23.62%-2.64M24.65%-3.09M97.94%-76K-118.68%-2.32M157.40%2.5M-482.56%-2.14M-167.08%-4.11M
Cash from discontinued investing activities
Operating cash flow -43.16%-19.49M-1.60%-22.75M0.49%-79M-35.01%-22.66M-18.67%-20.34M45.61%-13.62M-9.56%-22.39M31.36%-79.39M55.22%-16.78M32.45%-17.14M
Investing cash flow
Cash flow from continuing investing activities 59.95%39.99M-543.37%-88.64M271.08%44.98M-100.06%-7K-100.03%-9K350.64%25M133.10%19.99M-970.05%-26.29M170.42%11.6M81,307.50%32.48M
Net PPE purchase and sale -150.00%-7K-885.71%-69K97.99%-19K92.31%-7K-533.33%-19K104.19%14K98.64%-7K-5.72%-943K72.92%-91K96.91%-3K
Net investment purchase and sale 60.06%40M-542.87%-88.57M277.51%45M--0-99.97%10K359.18%24.99M133.40%20M-747.68%-25.35M172.45%11.7M56,892.98%32.49M
Cash from discontinued investing activities
Investing cash flow 59.95%39.99M-543.37%-88.64M271.08%44.98M-100.06%-7K-100.03%-9K350.64%25M133.10%19.99M-970.05%-26.29M170.42%11.6M81,307.50%32.48M
Financing cash flow
Cash flow from continuing financing activities -32.13%281K-1,800.00%-19K53,758.54%88.33M72,574.38%87.94M-10.53%-21K398.80%414K95.24%-1K-99.79%164K-78.08%121K-100.02%-19K
Net issuance payments of debt 65.96%-16K20.83%-19K-57.38%-96K-114.81%-4K25.00%-21K-62.07%-47K22.58%-24K22.78%-61K235.00%27K-27.27%-28K
Net common stock issuance ----------17.44M------------------0--------
Proceeds from stock option exercised by employees -35.57%297K--031,447.11%70.98M74,896.81%70.5M--0311.61%461K130.00%23K-78.51%225K-86.94%94K-50.00%9K
Cash from discontinued financing activities
Financing cash flow -32.13%281K-1,800.00%-19K53,758.54%88.33M72,574.38%87.94M-10.53%-21K398.80%414K95.24%-1K-99.79%164K-78.08%121K-100.02%-19K
Net cash flow
Beginning cash position -69.18%24.37M66.67%135.77M-56.43%81.46M-18.51%70.5M27.64%90.87M-25.49%79.07M-56.43%81.46M-15.37%186.98M-64.01%86.52M-62.10%71.19M
Current changes in cash 76.08%20.78M-4,551.65%-111.41M151.47%54.31M1,390.45%65.27M-232.88%-20.37M133.79%11.8M97.04%-2.4M-210.69%-105.52M90.53%-5.06M-70.83%15.33M
End cash Position -50.32%45.15M-69.18%24.37M66.67%135.77M66.67%135.77M-18.51%70.5M27.64%90.87M-25.49%79.07M-56.43%81.46M-56.43%81.46M-64.01%86.52M
Free cash flow -43.29%-19.5M-1.88%-22.82M1.64%-79.02M-34.32%-22.67M-18.72%-20.35M46.36%-13.61M-6.90%-22.39M31.08%-80.33M55.38%-16.87M32.69%-17.14M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --------------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data